Skip to content

Clinical trials

Muscular Dystrophy, Duchenne trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Country / region: Belgium Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20093
20102
20111
20122
20134
20142
20163
20174
20184
20194
20203
20212
20222
20234
20243
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated17
Recruiting10
Active, not recruiting6
Not yet recruiting2
Enrolling by invitation2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sarepta Therapeutics, Inc.8
BioMarin Pharmaceutical7
Santhera Pharmaceuticals6
PTC Therapeutics5
Italfarmaco4
Centre Hospitalier Universitaire de Liege3
Entrada Therapeutics, Inc.3
GlaxoSmithKline3
Edgewise Therapeutics, Inc.2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne56
Muscular Dystrophies11
Neuromuscular Diseases6
Muscular Diseases5
Genetic Diseases, Inborn4
Muscular Disorders, Atrophic4
Musculoskeletal Diseases4
Nervous System Diseases4
Genetic Diseases, X-Linked3
Myotonic Dystrophy2

Trials

Showing 51 to 56 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.